Related Experiment Video
Updated: Sep 12, 2025
08:02
Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
Published on: November 7, 2013
13.0K
Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery.
Uday Chintapula1, Shujing Liu1, Andres Fernandez Del Castillo2
1Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Small (Weinheim an Der Bergstrasse, Germany)
|August 7, 2025
Summary
Researchers developed a microfluidic method to create hybrid extracellular vesicle-lipid nanoparticle (EV-LNP) systems for drug delivery. These novel EV hybrids show improved targeting and enhanced cancer cell killing, advancing precision nanomedicine.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Drug Delivery Systems
Background:
- Extracellular vesicles (EVs) offer biocompatibility and targeting for drug delivery.
- Challenges in EV integrity and drug loading limit clinical use.
- Hybrid EV-lipid nanoparticle (LNP) systems show promise for targeted and combinatorial therapies.
Purpose of the Study:
- To develop a scalable microfluidic method for generating drug-loaded EV-LNP hybrids.
- To optimize the fusion process between EVs and LNPs.
- To evaluate the physicochemical properties and in vitro efficacy of the engineered EV hybrids.
Main Methods:
- A microfluidic platform utilizing a droplet-mediated squeezing mechanism for controlled EV-LNP fusion.
- Optimization of lipid composition and microfluidic parameters.
- Physicochemical characterization and in vitro evaluation of EV hybrids in melanoma models.
Main Results:
- Successful generation of scalable drug-loaded EV-LNP hybrids (EV hybrids).
- EV hybrids demonstrated enhanced in vitro targeting efficiency.
- Significant improvement in cytotoxic efficacy against melanoma cells in 2D and 3D cultures compared to individual EVs or LNPs.
Conclusions:
- A robust and scalable microfluidic platform for engineering EV hybrids was developed.
- EV hybrids represent a promising strategy for enhanced drug delivery and cancer therapy.
- This approach advances precision nanomedicine by overcoming limitations of traditional EVs and LNPs.
